Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Solid Biosciences (SLDB) Gains from Investment Securities (2018 - 2024)

Solid Biosciences (SLDB) has disclosed Gains from Investment Securities for 7 consecutive years, with -$319000.0 as the latest value for Q4 2024.

  • Quarterly Gains from Investment Securities rose 35.56% to -$319000.0 in Q4 2024 from the year-ago period, while the trailing twelve-month figure was -$720000.0 through Dec 2024, down 302.23% year-over-year, with the annual reading at $88000.0 for FY2024, 96.11% down from the prior year.
  • Gains from Investment Securities hit -$319000.0 in Q4 2024 for Solid Biosciences, down from $2.9 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $3.1 million in Q4 2020 to a low of -$495000.0 in Q4 2023.
  • Historically, Gains from Investment Securities has averaged $993788.5 across 5 years, with a median of $347997.0 in 2023.
  • Biggest five-year swings in Gains from Investment Securities: crashed 100.31% in 2021 and later soared 5924.6% in 2022.
  • Year by year, Gains from Investment Securities stood at $3.1 million in 2020, then plummeted by 89.77% to $319000.0 in 2021, then crashed by 60.14% to $127167.0 in 2022, then crashed by 489.25% to -$495000.0 in 2023, then soared by 35.56% to -$319000.0 in 2024.
  • Business Quant data shows Gains from Investment Securities for SLDB at -$319000.0 in Q4 2024, $2.9 million in Q3 2024, and $2.9 million in Q2 2024.